Analyst stock forecast
MaxCyte Forecast: $4.11 Analyst Target
MXCT has a $4.11 target, Strong Buy rating and 4 analysts. As of 2026-08-17.
Direct answer
MaxCyte's average price target is $4.11.
The target implies +211.2% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +84.1%, the high target implies +278.8%, and the range spans 194.7% of the current price.
Forecast evidence checked August 17, 2026.
Get free MaxCyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.32
- Average price target
- $4.11
- High price target
- $5.00
- Low price target
- $2.43
- Low target gap
- +84.1%
- Target upside
- +211.2%
- High target gap
- +278.8%
- Target range width
- 194.7%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 17, 2026
- Valid through
- August 24, 2026
Explore related company data
Read the frequently asked questions.
What is MaxCyte's average price target?
MaxCyte's verified average price target is $4.11. The target range is $2.43 to $5.00.
How far are MaxCyte's low and high targets from the recorded price?
The low target implies +84.1%, while the high target implies +278.8%.
How many analysts are included in MaxCyte's consensus?
The verified consensus includes 4 analysts.
How is MaxCyte's target upside or downside calculated?
The average target of $4.11 is divided by the recorded price of $1.32, then one is subtracted to produce +211.2%. This does not guarantee a future return.
When was MaxCyte's analyst forecast verified?
The data was verified on 2026-08-17. The dataset is valid through 2026-08-24.